Objective
To determine the associations between joint metabolism biomarkers and hand radiographic osteoarthritis (rOA, based on Kellgren Lawrence [KL] grade ≥2), symptoms, and function.
Design
Cross-sectional data were available for 663 participants (mean age 63 years, 63% white, 49% women). Three definitions of hand rOA were considered: 1) a composite measure involving at least 3 hand joints distributed bilaterally with 2 of 3 in the same joint group, including ≥1 distal interphalangeal joint, without metacarpophalangeal [MCP] swelling); 2) rOA in at least one joint of a group; and 3) number of joints with KL ≥2. We assessed hand symptoms and the 15-item AUSCAN (Likert format). We measured serum cartilage oligomeric matrix protein (sCOMP), hyaluronic acid (sHA),carboxy-terminal propeptide of type II collagen (sCPII), type II collagen degradation product (C2C), urinary C-terminal crosslinked telopeptide of type II collagen (uCTX-II), and urinary N-terminal crosslinked telopeptide (uNTX-1). Linear regression models were performed to assess associations between each biomarker with hand rOA, AUSCAN, and symptoms, adjusting for age, gender, race, current smoking/drinking status, BMI, and hip and knee rOA.
Results
In adjusted analyses, MCP (p<0.0001) and carpometacarpal rOA (p=0.003), and a higher number of hand joints with rOA (p=0.009), were associated with higher levels of sHA. Positive associations were seen between AUSCAN and hand symptoms and levels of sCOMP (p≤0.003) and sHA (p≤0.048).
Conclusion
Hand symptoms and higher AUSCAN scores were independently associated with higher levels of both sCOMP and sHA; hand rOA was associated only with sHA levels.